Literature DB >> 3669765

Consensus resolution: proposed criteria for evaluation of response to treatment in hairy cell leukemia.

.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3669765

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

Review 1.  Hairy cell leukemia: present and future directions.

Authors:  Robert J Kreitman
Journal:  Leuk Lymphoma       Date:  2019-05-09

2.  Retrospective Analysis of Hairy Cell Leukemia Patients Treated with Different Modalities as First Line: Real-Life Experience Over 20 years.

Authors:  Fergün Yılmaz; Dilan Atilla; Nagihan Akkaş; Hale Bülbül; Nur Soyer; Derya Demir; Demet Kiper; Aylin Avcı; Filiz Vural; Güray Saydam; Fahri Şahin; Mine Hekimgil; Nazan Özsan; Raika Durusoy; Bahriye Payzın
Journal:  Indian J Hematol Blood Transfus       Date:  2019-05-13       Impact factor: 0.900

Review 3.  Immunoconjugates in the management of hairy cell leukemia.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Best Pract Res Clin Haematol       Date:  2015-10-09       Impact factor: 3.020

Review 4.  Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies.

Authors:  H M Bryson; E M Sorkin
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

Review 5.  Update on hairy cell leukemia.

Authors:  Robert J Kreitman; Evgeny Arons
Journal:  Clin Adv Hematol Oncol       Date:  2018-03

6.  Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia.

Authors:  Alessandro Broccoli; Carolina Terragna; Laura Nanni; Marina Martello; Silvia Armuzzi; Claudio Agostinelli; Alice Morigi; Beatrice Casadei; Cinzia Pellegrini; Vittorio Stefoni; Elena Sabattini; Lisa Argnani; Pier Luigi Zinzani
Journal:  Hematol Oncol       Date:  2021-10-15       Impact factor: 4.850

Review 7.  Development of Recombinant Immunotoxins for Hairy Cell Leukemia.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Biomolecules       Date:  2020-08-03

8.  Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial.

Authors:  Rudolf Benz; Kornelius Arn; Martin Andres; Thomas Pabst; Michael Baumann; Urban Novak; Felicitas Hitz; Urs Hess; Reinhard Zenhaeusern; Yves Chalandon; Ulrich Mey; Sabine Blum; Daniel Rauch; Alix O'Meara Stern; Nathan Cantoni; Mario Bargetzi; Elena Bianchi-Papina; Davide Rossi; Jakob Passweg; Andreas Lohri; Simona Berardi; Qiyu Li; Anita Feller; Georg Stussi
Journal:  Blood Adv       Date:  2020-08-11

9.  Efficacy and Safety of Cladribine: Subcutaneous versus Intravenous Administration in Hairy Cell Leukemia Patients.

Authors:  Ola Khorshid; Alfred Elias Namour; Mosaad M El-Gammal; Tarek Yakout Mahmoud; Catherine Fortpied; Raafat Abdel-Malek; Safaa Ramadan
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-10-16       Impact factor: 2.576

10.  Retrospective Evaluation of Hairy Cell Leukemia Patients Treated with Three Different First-Line Treatment Modalities in the Last Two Decades: A Single-Center Experience.

Authors:  Şeniz Öngören; Ahmet Emre Eşkazan; Selin Berk; Tuğrul Elverdi; Ayşe Salihoğlu; Muhlis Cem Ar; Zafer Başlar; Yıldız Aydın; Nükhet Tüzüner; Teoman Soysal
Journal:  Turk J Haematol       Date:  2017-12-01       Impact factor: 1.831
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.